MIFH
YARW

Migdal Insurance & Financial Holdings’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed -$1K – 704
2021
Q4 		$1K Sell
1
-1
-50% -$1.07K ﹤0.01% 676
2021
Q3 		$2K Buy
+2
New +$3.88K ﹤0.01% 656

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Migdal Insurance & Financial Holdings's YARW Position: Q1 2022 in Review

Migdal Insurance & Financial Holdings sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2022, closing a stake of 1 share — an estimated $1K sold.

Migdal Insurance & Financial Holdings first reported a position in YARW in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q3 2021. 41 funds tracked by Wall St. Rank hold YARW as of Q1 2022.

  • Migdal Insurance & Financial Holdings reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 1 Yarrow Bioscience, Inc. Common Stock share in Q1 2022, an estimated $1K.
  • Migdal Insurance & Financial Holdings first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Yarrow Bioscience, Inc. Common Stock position peaked at $2K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2022.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.